Insider · CIK 0001259870
Target N Biotech V
Files at MTEM (Molecular Templates, Inc.). First filing Nov 18, 2024, latest Nov 18, 2024.
In brief
Target N Biotech V files SEC Form 4 as 10% owner at MTEM (Molecular Templates, Inc.). Since Nov 18, 2024, Target N Biotech V has reported 0 open-market buys worth $0 and 1 open-market sell worth $846k, the latest filed on Nov 18, 2024.
A track record needs three past buys with six months of prices behind them; Target N Biotech V has 0, so none is measured yet.
The newest scored trade: sold $846k of MTEM on Nov 14, 2024, filed Nov 18, 2024, scored 55 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 55Moderate | MTEMsell Molecular Templates, Inc. | $846k 1,279,820 shares | -100% | - |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 14, 2024 | MTEM Molecular Templates, Inc. | SOpen-market sale Common Stock | -1,279,820 | $0.66 | $846k | 0 | Nov 18, 2024 |
| Apr 2, 2024 | MTEM Molecular Templates, Inc. | POpen-market purchase Prefunded Warrants (right to buy)derivative | +134,667 | $2.35 | $316k | 134,667 | Nov 18, 2024 |
| Apr 2, 2024 | MTEM Molecular Templates, Inc. | POpen-market purchase Common Warrants (right to buy)derivative | +769,334 | $0.13 | $96k | 769,334 | Nov 18, 2024 |
Questions about Target N Biotech V
Answered from the filings on this page, as of the latest one.
Is Target N Biotech V buying or selling?
Not in the last 12 months. Target N Biotech V's latest open-market trade on SEC Form 4 was sold $846k of MTEM on Nov 14, 2024.
How did Target N Biotech V's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Target N Biotech V has 0.
Where does Target N Biotech V file Form 4?
Target N Biotech V has filed Form 4 at MTEM (Molecular Templates, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.